Schwalm Cynthia
Insider CIK 1741455 · KDMN Director · GTHX Director · CLBS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2026-01-09 | 2026-01-13 | 30,456 | — | $0 | 95,446 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2025-01-09 | 2025-01-13 | 15,789 | — | $0 | 64,990 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer | 2024-09-18 | 2024-09-18 | 20,000 | — | $0 | 15,889 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | U Tender | 2024-09-18 | 2024-09-18 | 15,889 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2024-06-13 | 2024-06-14 | 10,000 | — | $0 | 35,889 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2024-01-09 | 2024-01-11 | 19,480 | — | $0 | 49,201 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2023-06-15 | 2023-06-16 | 10,000 | — | $0 | 25,889 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2023-01-09 | 2023-01-11 | 20,000 | — | $0 | 29,721 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2022-06-23 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2022-06-23 | 2022-06-24 | 10,000 | — | $0 | 15,889 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2022-01-10 | 2022-01-12 | 65,430 | — | $0 | 145,847 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 100,000 | $7.21 | $721.0K | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 85,034 | $5.06 | $430.3K | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 96,975 | $5.92 | $574.1K | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 64,935 | $7.23 | $469.5K | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer | 2021-11-09 | 2021-11-09 | 10,850 | $9.50 | $103.1K | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | G Gift | 2021-11-08 | 2021-11-09 | 20,150 | — | $0 | 10,850 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 19,620 | — | $0 | 19,620 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2021-06-17 | 2021-06-21 | 4,389 | — | $0 | 5,889 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2021-05-12 | 2021-05-13 | 96,975 | — | $0 | 96,975 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2021-01-11 | 2021-01-12 | 37,735 | — | $0 | 80,417 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2020-06-11 | 2020-06-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2020-05-13 | 2020-05-14 | 85,034 | — | $0 | 85,034 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | P Buy | 2020-03-12 | 2020-03-12 | 9,307 | $3.24 | $30.2K | 9,307 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | P Buy | 2020-03-12 | 2020-03-12 | 21,693 | $3.24 | $70.3K | 31,000 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2020-01-13 | 2020-01-14 | 18,292 | $3.28 | $60.0K | 42,682 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2019-05-15 | 2019-05-16 | 100,000 | $2.29 | $229.0K | 164,935 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2019-01-22 | 2019-01-23 | 64,935 | — | $0 | 64,935 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2019-01-14 | 2019-01-16 | 12,121 | $4.95 | $60.0K | 24,390 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | P Buy | 2018-12-26 | 2018-12-27 | 1,420 | $18.45 | $26.2K | 1,500 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award deriv | 2018-11-07 | 2018-11-08 | 12,269 | — | $0 | 12,269 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2018-06-07 | 2018-06-11 | 20,000 | — | $0 | 20,000 | SEC↗ |